Form D · Other Investment Fund
Janus Henderson Biotech Innovation Fund Ltd
Grand Cayman, E9 · CIK 0002131527
Offering snapshot reported Jun 9, 2026 · SEC filing
- Reported sold
- $441M Indefinite offering
- Investors reported
- 81 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Oct 29, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 9, 2026 | Initial | $441,173,044 | No comparison | 81 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-586706
Source: Form D, filed Jun 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matteo Candolfini | Director |
| Toby Hiscock | Director |
| N/A Janus Henderson Investors Us Llc | Promoter |
| Kenneth Lubbock | Director |
| Hugh Ward | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
C/O Maples Corporate Services Ltd Box 309, Ugland House
Grand Cayman, E9, KY1-1104
Grand Cayman, E9, KY1-1104